查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1632578

全球兽药製剂市场：市场规模、份额及趋势分析（按产品、动物类型、给药途径、剂型、地区和细分，2025-2030 年）

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

动物药品市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，到 2030 年全球兽药市场规模预计将达到 24.5 亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 8.29%。推动市场成长的关键因素包括宠物数量的增加、庞大的兽医医疗保健支出、饲主对特种药物的认识不断提高、品牌动物用药品高成本、宠物人性化的趋势以及对定制兽药复合药物的需求不断增加。

与全球其他几个产业一样，COVID-19 疫情在 2020 年对动物保健药品市场产生了负面影响。 COVID-19 对动物保健系统最显着的影响是供应链中断、销售下降、需求放缓以及法规和政策变化带来的营运挑战。许多地区进入全州封锁状态，并实施了对人员和货物流动的限制，严重影响了製造商、兽医药房和兽医护理服务提供者。例如，根据美国兽医协会的数据，2020年4月，约有60%的兽医诊所因冠状病毒疫情而取消或推迟了服务，而到2020年7月，这一数字已下降至约30%。因此，COVID-19 的影响正在阻碍市场成长。

动物用药品配製填补了缺乏可用于兽医护理的核准药物和替代动物用药品而留下的空白。当难以获得 FDA 批准的针对特定疾病的药物时，复方药物可以成为治疗多种动物疾病的更好选择。例如，咀嚼片可能是特定剂型的商业性核准产品，并建议用于某些动物物种，但不适合用于猫和异国风宠物等动物。同样，广泛使用的商业药物对某些动物来说有令人不愉快的味道，限制了给药率。在这些情况下，特别是对于难以给药的药物，最好使用兽医製剂。

疫情期间，宠物拥有量大幅增加，带动兽医保健基础设施增加，推动兽医组合药物市场的发展。根据美国防止虐待动物协会（ASPCA）2021年5月发布的报告，自新冠疫情爆发以来，五分之一的家庭养了猫或狗。疫情期间收养引发了人们对宠物健康兴趣的增加，预计将推动未来几年兽药市场的扩张。

同样，随着市场参与企业关注兽医健康计划和倡议，全球兽药市场预计将扩大。例如，2021 年 6 月，Covetrus 收购了 VCP，这是一个管理兽医健康计划的平台，为大约 1,000 家诊所提供服务，目前透过 VCP 支持的健康计划使超过 350,000 隻宠物受益。 Covetrus 利用 VCP 提供的基础设施和技术平台，为兽医提供新的方式与宠物饲主建立更密切的关係，并推动更好的业务和临床结果。

动物药品市场：分析概述

  • 根据动物类型，宠物产业预计将在 2024 年占据最大的收益占有率。这是由于饲养宠物的人数不断增加、在动物身上的支出不断增加以及对宠物复合药物的需求不断增加。
  • 根据产品，中枢神经系统药物部分在 2024 年占据约 33% 的市场占有率。中枢神经系统药物是治疗宠物行为改变、失明、癫痫和癫痫等神经系统疾病最常使用的药物。荷尔蒙和替代药物是一个快速成长的领域，成长速度超过 9.0%，因为它们更适合且更有效治疗动物荷尔蒙失衡。
  • 在给药途径中，口服药物是最受欢迎、最方便和最被接受的给药途径，因此口服药物部分将在 2024 年占据最大的市场占有率，超过 53%。另一方面，依给药途径划分，外用製剂是成长最快的领域，预测期内成长率超过 9.0%。
  • 根据剂型，悬浮液部分将在 2024 年占据最大的收入份额，约 49%，因为悬浮液是动物最常用的剂型。由于溶液相对于其他固态剂型具有多种优势，预计未来几年溶液部分将实现最高的复合年增长率，超过 8%。与固态形式相比，溶液通常吸收更快，并且对胃肠黏膜更温和。此外，与悬浮液不同，溶液在储存过程中不会发生相分离问题。因此，预计溶液配方在预测期内将变得更加流行。
  • 由于饲养宠物数量增加、兽医医疗费用上涨以及兽医製剂需求旺盛，预计到 2024 年北美将占据地区最高市场占有率，约 40%。由于宠物人性化的不断提高、兽医医疗保健支出的不断增加以及低成本兽药的普及，预计亚太地区的复合年增长率将达到约 10.0%，为最快的增长地区。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章动物药品市场：驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章动物药品市场：按产品分類的业务分析

  • 按产品市场占有率（2024 年和 2030 年）
  • 产品仪表板
  • 依产品分類的市场规模预测及趋势分析（2018-2030）
  • 抗感染剂
  • 抗发炎剂
  • 荷尔蒙和替代品
  • 中枢神经系统 (CNS) 药物
  • 其他产品

第 5 章动物药品市场：按动物类型进行的业务分析

  • 各动物类型的市场占有率（2024 年和 2030 年）
  • 动物物种仪表板
  • 按动物类型分類的市场规模预测及趋势分析（2018-2030 年）
  • 宠物
  • 家畜

第六章动物药品市场：依给药途径进行的业务分析

  • 按管理途径分類的市场占有率（2024 年和 2030 年）
  • 管理路线仪表板
  • 依管理途径分類的市场规模预测及趋势分析（2018-2030 年）
  • 口服药物
  • 注射剂
  • 外用製剂
  • 其他路线

第 7 章动物药品市场：按剂型分類的业务分析

  • 按剂型分類的市场占有率（2024 年和 2030 年）
  • 按剂型分類的仪表板
  • 按剂型分類的市场规模预测及趋势分析（2018-2030年）
  • 暂停
  • 解决方案
  • 胶囊

第 8 章动物药品市场：区域估计和趋势分析（按产品、动物类型、给药途径和剂型）

  • 按地区分類的市场占有率分析（2024 年和 2030 年）
  • 区域市场仪表板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 市场参与企业概况
  • 公司市场地位分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • WEDGEWOOD PHARMACY
    • Vimian
    • Pharmaca
    • Akina Animal Health
    • Triangle Compounding
    • Davis Islands Pharmacy and Compounding Lab
    • Custom Med Compounding Pharmacy
    • Central Compounding Center South
    • Wellness Pharmacy of Cary
    • Miller's Pharmacy

第十章 重点

Product Code: GVR-4-68040-040-6

Animal Drug Compounding Market Growth & Trends:

The global animal drug compounding market size is anticipated to reach USD 2.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.29% from 2025 to 2030. The key factors driving the market growth include a rise in pet adoption, huge animal healthcare spending, increased pet owner awareness regarding specialty pharmaceuticals, the high cost of branded veterinary products, pet humanization trends, and an increase in the demand for custom-made, compounded animal medications.

The COVID-19 pandemic had a negative impact on the market for animal drug compounding in 2020, just like on several other global industries. The most significant effects of COVID-19 on the veterinary healthcare system are supply chain disruptions, a drop in sales, a slowdown in demand, and operational challenges brought on by shifting regulations and policies. Manufacturing firms, veterinary pharmacies, and animal care service providers were severely impacted as many areas entered state-wide lockdowns and imposed restrictions on the movement of people and goods. For instance, according to the American veterinary medical association, in April 2020, approximately 60% of veterinary practices were canceled or delayed due to the outbreak of coronavirus and in July 2020, the number of veterinary practices declined to about 30%. Thus, the impact of COVID-19 has hampered market growth.

Compounding veterinary drugs fills the gaps left by less readily available licensed drugs for veterinary treatment and other veterinary medication alternatives. Compounded medications are a better choice for treating a wide range of animal diseases when FDA-approved drugs are difficult to find for certain medical conditions. For instance, chewable tablets are commercially approved products in specific dosage forms and are suggested for use in certain animal species yet are unacceptable for use in animals such as cats or exotic pets. Similarly, widely available medications have an unpleasant taste for some animals limiting the administering rate. In this case, animal drug compounding is preferred, particularly for difficult-to-administer medications.

During the pandemic, pet adoption considerably increased, leading to an increased animal healthcare infrastructure and driving the market for compounded medications for animals. According to a report published by the American Society for the Prevention of Cruelty to Animals (ASPCA) in May 2021, one in every five families had adopted a cat or dog since the COVID-19 pandemic began. The increased focus on pet health brought on by adoptions during the pandemic is expected to drive the expansion of the animal drug compounding market over the coming years.

Similarly, the global animal drug compounding market is expected to expand due to market players focusing on programs and initiatives concerning veterinary health. For instance, in June 2021, Covetrus acquired VCP, a platform for administering veterinary wellness plans that serves about 1,000 practices and presently benefits over 350,000 pets through wellness plans that are enabled by VCP. Covetrus will make use of the infrastructure and technology platform provided by VCP to offer new methods for vets to develop closer bonds with their pet owners and produce better results in terms of both business and healthcare.

Animal Drug Compounding Market Report Highlights:

  • Based on animal type, the companion animals segment accounted for the largest revenue share in 2024. This can be attributed to the increasing adoption of pet animals, the rise in animal expenditure, and the increasing demand for compounding medication for pet animals.
  • Based on products, the CNS agents segment dominated with a market share of around 33% in 2024, as CNS agents are the most frequently prescribed medication for treating neurological conditions such as changes in behavior, blindness, seizures, epilepsy, etc., in pets. Hormones & Substitutes is the fastest-growing segment with a rate of over 9.0% since it is better and more potent for hormonal imbalance treatment in animals.
  • Among routes of administration, the oral segment held the largest market share of more than 53 % in 2024, as oral formulations are the preferred, easy, and more acceptable route of drug administration. Whereas, topical is the fastest-growing segment among the routes of administration, with a growth rate of over 9.0% during the forecast period.
  • Based on dosage form, the suspensions segment accounted for the largest revenue share of about 49% in 2024, as suspensions were the most dispensed compounded dosage form for animals. The Solutions segment is estimated to register the highest CAGR of over 8% in the coming years owing to the several benefits of the solution compared to another solid dosage form. Solutions are usually more GI mucosa-friendly than solid dosage forms as they are more quickly absorbed. In addition, unlike suspensions, phase separation during storing is not an issue with solutions. Thus, solutions are expected to gain popularity during the forecast period.
  • North America attributed the largest share of about 40% of the market by region in 2024, owing to an increase in pet ownership together with rising animal health expenditure and high demand for animal drug compounding. While Asia pacific is expected to grow at the fastest CAGR of about 10.0% due to an increase in pet humanization, growing animal healthcare expenditure, and the availability of low-cost animal compounding medications.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Type
    • 1.2.3. Route of Administration
    • 1.2.4. Dosage Form
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Animal Drug Compounding Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Animal Drug Compounding Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Anti-infective Agents
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Anti-inflammatory Agents
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Hormones & Substitutes
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. CNS Agents
    • 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Other Products
    • 4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Animal Drug Compounding Market: Animal Type Business Analysis

  • 5.1. Animal Type Market Share, 2024 & 2030
  • 5.2. Animal Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
  • 5.4. Companion Animal
    • 5.4.1. Dogs
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Cats
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Horses
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Livestock Animal
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Animal Drug Compounding Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Oral
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Injectable
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Topical
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Other Routes
    • 6.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Animal Drug Compounding Market: Dosage Form Business Analysis

  • 7.1. Dosage Form Market Share, 2024 & 2030
  • 7.2. Dosage Form Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
  • 7.4. Suspensions
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Solutions
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Capsules
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Animal Drug Compounding Market: Regional Estimates & Trend Analysis by Product, Animal Type, Route of Administration, and Dosage Form

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Mexico animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Norway animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Denmark animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. South Korea animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Australia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Argentina animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Saudi Arabia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. UAE animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Kuwait animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. WEDGEWOOD PHARMACY
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Vimian
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Pharmaca
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Akina Animal Health
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Triangle Compounding
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Davis Islands Pharmacy and Compounding Lab
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Custom Med Compounding Pharmacy
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Central Compounding Center South
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Wellness Pharmacy of Cary
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Miller's Pharmacy
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives

Chapter 10. Key Takeaways

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 4 Global Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 7 Global Animal Drug Compounding Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 10 North America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 North America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 13 U.S. Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 U.S. Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 17 Canada Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 21 Mexico Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Mexico Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 25 Europe Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 Europe Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 30 Germany Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 34 UK Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 35 UK Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 UK Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 UK Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 38 France Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 39 France Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 France Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 France Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 42 Italy Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Italy Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 46 Spain Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 50 Denmark Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Denmark Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 54 Sweden Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 55 Sweden Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Sweden Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 58 Norway Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 59 Norway Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Norway Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Norway Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 67 China Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 68 China Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 China Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 China Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 71 Japan Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 72 Japan Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Japan Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 75 India Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 76 India Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 India Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 India Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 79 South Korea Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 South Korea Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Korea Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 83 Australia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 84 Australia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 85 Australia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Australia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 87 Latin America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 90 Latin America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Latin America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 92 Brazil Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Brazil Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 Brazil Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 96 Argentina Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 98 Argentina Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Argentina Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 100 Middle East & Africa Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 101 Middle East & Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 102 Middle East & Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 105 South Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 South Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 South Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 113 UAE Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 115 UAE Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 116 UAE Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Animal Drug Compounding Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Animal Drug Compounding Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Animal Drug Compounding Market, for Anti-infective Agents, 2018 - 2030 (USD Million)
  • Fig. 16 Global Animal Drug Compounding Market, for Anti-inflammatory Agents, 2018 - 2030 (USD Million)
  • Fig. 17 Global Animal Drug Compounding Market, for Hormones & Substitutes, 2018 - 2030 (USD Million)
  • Fig. 18 Global Animal Drug Compounding Market, for CNS Agents, 2018 - 2030 (USD Million)
  • Fig. 19 Global Animal Drug Compounding Market, for Other Products, 2018 - 2030 (USD Million)
  • Fig. 20 Global Animal Drug Compounding Market, for Animal Type, 2018 - 2030 (USD Million)
  • Fig. 21 Global Animal Drug Compounding Market, for Companion Animal, 2018 - 2030 (USD Million)
  • Fig. 22 Global Animal Drug Compounding Market, for Dogs, 2018 - 2030 (USD Million)
  • Fig. 23 Global Animal Drug Compounding Market, for Cats, 2018 - 2030 (USD Million)
  • Fig. 24 Global Animal Drug Compounding Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Animal Drug Compounding Market, for Livestock Animal, 2018 - 2030 (USD Million)
  • Fig. 26 Global Animal Drug Compounding Market, for Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 27 Global Animal Drug Compounding Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 28 Global Animal Drug Compounding Market, for Injectable, 2018 - 2030 (USD Million)
  • Fig. 29 Global Animal Drug Compounding Market, for Topical, 2018 - 2030 (USD Million)
  • Fig. 30 Global Animal Drug Compounding Market, for Other Routes, 2018 - 2030 (USD Million)
  • Fig. 31 Global Animal Drug Compounding Market, for Dosage Form, 2018 - 2030 (USD Million)
  • Fig. 32 Global Animal Drug Compounding Market, for Suspensions, 2018 - 2030 (USD Million)
  • Fig. 33 Global Animal Drug Compounding Market, for Solutions, 2018 - 2030 (USD Million)
  • Fig. 34 Global Animal Drug Compounding Market, for Capsules, 2018 - 2030 (USD Million)
  • Fig. 35 Regional Outlook, 2024 & 2030
  • Fig. 36 North America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 63 Company categorization
  • Fig. 64 Company market position analysis
  • Fig. 65 Strategic framework